FEIBA PROOF: A Prospective, open-label, randomized, parallel study with FEIBA NF to evaluate the efficacy and safety of prophylactic versus on-demand treatment in haemophilia A or B subjects with inhibitors

Sandra V. Antunes, Srilatha Tangada, Oleksandra Stasyshyn, Vasily Mamonov, Julia Phillips, Norma Guzman-Becerra, Jennifer Doralt, Bruce Ewenstein, Wing Yen Wong